Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy

Diagnostics: Liquid biopsy detects recurrence but lacks sensitivity A blood test can detect disease recurrence among women with triple-negative breast cancer (TNBC), but lacks sensitivity for distant relapse. A team led by Milan Radovich from Indiana University School of Medicine in Indianapolis, US...

Full description

Bibliographic Details
Main Authors: Yu-Hsiang Chen, Bradley A. Hancock, Jeffrey P. Solzak, Dumitru Brinza, Charles Scafe, Kathy D. Miller, Milan Radovich
Format: Article
Language:English
Published: Nature Publishing Group 2017-07-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-017-0028-4

Internet

https://doi.org/10.1038/s41523-017-0028-4

Similar Items